Volume Spike Investor

Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) is one of the leading volume stocks this morning on NASDAQ. Unfortunately for holders, it is a major downside volume alert to yet another 52-week low.  An FDA non-approvable letter is the culprit.
The biotech is down now more than 60% at $1.24 and its prior 52-week trading range was [...]